INVO Fertility (IVF) Fundamental Analysis: Revenue, Earnings & Valuation

0.84 / 10

Underperform

Fundamental analysis rates IVF as Underperform with a 0.8/10 score. Profit‑MV and Asset‑MV provide modest positives, while Cash‑MV, ROA and profit margins are deeply negative. The overall view is selective, indicating weak financial strength.

Analysis Checks(2/10)

Revenue-MV

Value2.03

Score1/3

Weight4.86%

1M Return-0.97%

ROA (%)

Value-77.61

Score0/3

Weight21.14%

1M Return-6.58%

Net cash flow from operating activities / Operating revenue (%)

Value-133.89

Score0/3

Weight21.18%

1M Return-6.63%

Profit-MV

Value0.40

Score2/3

Weight-18.07%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-103.48

Score0/3

Weight21.14%

1M Return-6.58%

EBIT / Total operating revenue (%)

Value-126.88

Score1/3

Weight3.56%

1M Return-0.83%

Asset-MV

Value-0.49

Score2/3

Weight-3.09%

1M Return0.57%

Net profit / Total operating revenue (%)

Value-481.81

Score0/3

Weight21.57%

1M Return-6.68%

Cash-MV

Value-0.09

Score1/3

Weight17.13%

1M Return-4.16%

Net profit / Total profit (%)

Value344.86

Score1/3

Weight10.58%

1M Return-2.39%

Is IVF fundamentally strong?

IVF scores 0.84/10 on fundamentals and holds a Premium valuation at present. Backed by its -194.47% ROE, -417.01% net margin, -0.14 P/E ratio, 0.69 P/B ratio, and -225.06% earnings growth, these metrics solidify its Underperform investment rating.